Silicosis is a chronic occupational lung disease caused by inhalation of respirable crystalline silica particles, particularly crystalline forms such as quartz. The disease is a pneumoconiosis, meaning a lung disorder caused by inhalation of mineral dust with characteristic pathological changes. Respirable silica particles are sufficiently small to penetrate deeply into the respiratory tract and reach the alveoli, where they can provoke persistent inflammation and fibrosis. Silicosis has historically affected workers in mining, quarrying, stone cutting, construction, ceramics, foundries and other industries involving silica-containing materials. Modern exposure concerns also include engineered or manufactured stone processes where high concentrations of respirable silica can be generated during cutting, grinding or fabrication.
The pathogenesis of Silicosis involves deposition of silica particles in the distal lung followed by activation and injury of alveolar macrophages. Macrophages attempt to engulf the particles but can undergo cellular injury and release inflammatory mediators and reactive oxygen species. This stimulates recruitment of additional immune cells and activation of fibroblasts, resulting in collagen deposition and formation of silicotic nodules. With continuing exposure, fibrosis can become extensive and may distort normal lung architecture. The disease is therefore not simply dust physically blocking the lungs; it represents a chronic biological response to persistent mineral particles. The fibrotic process can continue after exposure has stopped, although progression rates vary among individuals and depend on cumulative exposure and other factors.
Silicosis is commonly classified according to the intensity and duration of exposure and the resulting clinical course. Chronic silicosis usually develops after many years of lower-level exposure, whereas accelerated silicosis can develop over a shorter period after substantial exposure. Acute silicosis is uncommon but can occur following very high concentrations and may produce severe respiratory impairment over a relatively short period. Symptoms of chronic disease can initially be absent, with abnormalities detected through occupational surveillance. Later manifestations may include exertional breathlessness, persistent cough and reduced exercise tolerance. Advanced fibrosis can produce substantial impairment in gas exchange and respiratory function.
Diagnosis incorporates occupational exposure history, clinical assessment and imaging. Chest radiography can demonstrate characteristic small rounded opacities and other changes, while high-resolution computed tomography can provide greater detail when necessary. Pulmonary function tests can quantify restriction, airflow abnormalities and impaired gas transfer, although results depend on disease stage and coexisting conditions. The diagnosis requires credible exposure to respirable crystalline silica because radiographic abnormalities can arise from several other diseases. Differential diagnoses include other pneumoconioses, granulomatous disorders, tuberculosis and other causes of diffuse or nodular lung abnormalities. Occupational history is therefore as important as imaging findings.
Silicosis substantially increases susceptibility to certain complications, including tuberculosis and other mycobacterial infections. The mechanisms are related partly to impaired macrophage function and altered pulmonary host defence. Chronic silicosis can also coexist with chronic obstructive pulmonary disease, particularly when smoking or other inhalational exposures are present. Progressive fibrosis can lead to respiratory failure, pulmonary hypertension and significant functional limitation in advanced cases. There is no simple medication that removes deposited silica or reverses established pulmonary fibrosis. Management therefore emphasises preventing additional exposure, treating complications, monitoring lung function and providing supportive respiratory care.
Prevention depends on controlling respirable crystalline silica at its source. Wet cutting and processing, local exhaust ventilation, enclosure, process isolation and appropriate engineering controls can substantially reduce airborne dust. Work practices should prevent unnecessary disturbance of settled dust, and suitable respiratory protective equipment can provide additional protection where engineering measures cannot adequately control exposure. Air monitoring can help determine whether controls are effective, while health surveillance may identify early abnormalities in exposed workers. A crucial distinction is between visible dust and respirable silica: a workplace can contain hazardous respirable particles even when airborne dust is not visually dramatic, so relying on appearance alone is inadequate.
Silicosis has historical significance as one of the best-established occupational lung diseases and remains important because preventable exposure continues in industries involving silica-containing materials. The disease is distinct from simple temporary irritation because fibrosis represents permanent structural change. It is also distinct from asbestos-related lung disease because the causal mineral, particle characteristics and pathological patterns differ. Workers may underestimate risk when using modern materials or processes because silica-containing products can appear industrially clean, yet high-energy cutting and grinding can generate very fine particles. The most effective strategy is therefore exposure prevention rather than relying on treatment after fibrosis has developed.
A common misconception is that only miners develop Silicosis. In reality, many occupations can involve hazardous respirable crystalline silica exposure, especially where materials are cut, drilled, crushed, polished or otherwise mechanically processed. Another misconception is that symptoms must appear before disease is present; early silicosis can be asymptomatic and may be identified through surveillance. Silicosis is also not contagious and cannot spread between workers. Prognosis depends heavily on disease severity and ongoing exposure, and advanced fibrosis may be irreversible. Because silica exposure can also contribute to other respiratory risks, occupational control programmes need to address the actual generation and inhalation of respirable particles rather than relying solely on general dust suppression.
